Pubblicazioni Scientifiche
Dermatologia22 mag 2023
An update on Epstein-Barr virus-and human T-lymphotropic virus
The Epstein-Barr virus (EBV) is a DNA virus that infects 90% of the human population
22 mag 2023
An update on viral-induced cutaneous
Viral-induced cutaneous T-cell lymphomas are an uncommon group of lymphoproliferative disorders characterized by a viral infection
22 mag 2023
Clinical management of melanocytic tumours
Little guidance is currently available for managing patients with melanocytic tumours
04 mag 2023
Quality of life measurement in rosacea
The European Academy of Dermatology and Venereology (EADV) Task Forces (TFs) on Quality of Life (QoL) and Patient-Oriented Outcomes and Acne
04 mag 2023
Criteria used to define tumor
Determining tumor necrosis factor-alpha inhibitors (anti-TNF-α) failure is still a challenge in the management of moderate-to-severe
04 mag 2023
Efficacy and safety of abrocitinib monotherapy in adolescents and adults
Differences in atopic dermatitis (AD) disease course and manifestation with age may extend to treatment response
17 apr 2023
Bimekizumab maintenance of response through three years
Given the chronic nature of psoriasis and the loss of response that can be observed with therapies over time
17 apr 2023
Multidisciplinary Approach to the Diagnosis
Mycosis fungoides is the most common primary cutaneous T-cell lymphoma
17 apr 2023
The impact of dupilumab
Skin barrier dysfunction plays an important role in atopic dermatitis (AD) aetiopathogenesis
31 mar 2023
Clinical Review of Mucosal Melanoma
Mucosal melanoma is a rare neoplasm. Late diagnosis is caused by occult anatomic sites and scarcity of symptoms.
31 mar 2023
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune
Paraneoplastic pemphigus (PNP), also called paraneoplastic autoimmune multiorgan syndrome (PAMS), is a rare autoimmune disease with mucocutaneous and multi-organ involvement
31 mar 2023
2022 European guideline for the management of balanoposthitis
This guideline is an update to the 2014 edition of the European guideline for the management of balanoposthitis
13 mar 2023
Topical treatments for Kaposi sarcoma
While treatment options exist for solitary or disseminated Kaposi sarcoma
13 mar 2023
British Association of Dermatologists guidelines for the management of people
British Association of Dermatologists guidelines for the management of people with cutaneous squamous
13 mar 2023
Development and Validation of the Morphea Activity
Morphea is an insidious inflammatory disorder of the skin and deeper tissues. Determining disease activity is challenging yet important to medical decision-making and patient outcomes
06 mar 2023
Nicotinamide for Skin-Cancer Chemoprevention
Immunosuppressed organ-transplant recipients have an increased incidence of, and mortality from, skin cancer
06 mar 2023
Wound healing and microbiome
Skin wounds are common and represent a major public health and economical problem
06 mar 2023
Monkeypox outbreak, vaccination, and treatment implications for the dermatologic patient
Rapid human-to-human transmission of monkeypox has created a public health emergency requiring prompt, multidisciplinary attention
20 feb 2023
Psoriatic Arthritis in Males and Females
To assess any differences and similarities in psoriatic arthritis (PsA) between sexes.
20 feb 2023
A Review on the Safety of Using JAK Inhibitors in Dermatology
Janus kinase (JAK) inhibitors are disease-modifying agents with efficacy in treating a spectrum of burdensome dermatologic conditions